Abstract
Introduction
Carcinoma is the second most common cause of death worldwide. The neutrophil–lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) are essential markers of inflammation and tumorigenesis in various cancers including head and neck cancers. Pretreatment platelet- lymphocytic ratio can be used as an independent predictor of mortality whereas neutrophil- lymphocytic ratio is an independent predictor of recurrence. The main aim of this study is to compare the pre-treatment neutrophil lymphocyte ratio and platelet-lymphocyte ratio in the patients of head and neck malignancies with those of the control group.
Material and Method
100 patients with histologically diagnosed cases of head and neck malignancies. Age and sex matched healthy subjects attending Otorhinolaryngology out-patient department for any other complaints (100 control subjects). Complete blood count had been done to calculate absolute neutrophil count and absolute lymphocyte count.
Results
The mean age of the subjects in the study group was 55.73 ± 11.56 years. In control group, the mean age group was 54.11 ± 10.46 years. NLR and PLR significantly increased in cases than controls. NLR associated with T stage, histological type and histological grade but not with site and nodal involvement. PLR associated with T stage, metastasis but not with the histological grade, histological type, site and nodal involvement.
Conclusion
From this study, we conclude that pre-treatment NLR and PLR were closely associated both with the size of primary tumor and also with the stage of malignant disease in patients of head and neck malignancies.
Similar content being viewed by others
References
Mantovani A, Allaveni P, Sica A et al (2008) Cancer-related inflammation. Nature 454(7203):436–444
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Jenne CN, Urrutia R, Kubes P (2013) Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol 35:254–261
Tazzyman S, Lewis CE, Murdoch C (2009) Neutrophils: key mediators of tumor angiogenesis. Int J Exp Pathol 90:222–231
Zhang J, Qiao X, Shi H et al (2016) Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation. Tumour Biol 37:5397–5404
Hoffmann TK, Dworacki G, Tsukihiro T et al (2002) Spontaneous apoptosis of circulating T lymphocytes in patients of head and neck cancer and its clinical importance. Clin Cancer Res 8:2553–2562
Sumner WA, Stokes WA, Oweida A et al (2017) Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy. J Transl Med 15(1):168
Chen L, Zeng H, Yang J et al (2018) Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma. BMC Cancer 18(1):816
Nakayama M, Gosho M, Hirose Y et al (2018) Modified combination of platelet count and neutrophil “to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer. Head Neck 40(6):1138–1146
Seetohul YB, Singh V, Jain RK et al (2020) Prognostic value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in head and neck malignancies. Indian J Otolaryngol Head Neck Surg 72:128–132
Mittal S, Krishnamurthy A, Kothandaraman SK et al (2020) Exploring the prognostic significance of the pretreatment inflammatory markers in hypopharyngeal cancers: a retrospective analysis. Cancer Res Stat Treat 3:437–444
Tazeen S, Prasad K, Harish K et al (2020) Assessment of pretreatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in prognosis of oral squamous cell carcinoma. J Oral Maxillofac Surg 78(6):949–960
Chen S, Guo J, Feng C, Ke Z, Chen L, Pan Y (2016) The preoperative platelet–lymphocyte ratio versus neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Therapeutic Adv Med Oncol 8(3):160–167
Lee S, Kim DW, Kwon S, Kim HJ, Cha IH, Nam W (2020) Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system. Sci Rep 10(1): 12111
Kuzucu I, Güler ̇ I, Kum RO et al (2020) Increased neutrophil lymphocyte ratio and platelet lymphocyteratio in malignant parotid tumors. Braz J Otorhinolaryngol 86:105–110
Abelardo E, Davies G, Kamhieh Y et al (2020) Are inflammatory markers significant prognostic factors for head and neck cancer patients? ORL J Otorhinolaryngo Relat Spec 82(5):235–244
Szilasi Z, Jósa V, Zrubka Z et al (2020) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic markers of survival in patients with head and neck tumours—results of a retrospective multicentric study. Int J Environ Res Public Health 17:1742
Ni L, Tao J, Xu J et al (2020) Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 301(1):251–261
Hsueh C, Tao L, Zhang M et al (2017) The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer. Oncotarget 8(36):6051460527
Acmaz G, Aksoy H, Unal D et al (2014) Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer Prev 15(4):1689–1692
Duzlu M, Karamert R, Tutar H et al (2015) Neutrophil lymphocyte ratio findings and larynx carcinoma: a preliminary study in Turkey. Asian Pac J Cancer Prev 16:351–354
EnginŞengül Y, Murat Ş, Musa Ö (2016) Prognostic value of mean platelet volume and platelet to lymphocyte ratio in laryngeal carcinoma. J Clin Exp Investig 7(2):134–138
Zhou H, Song P, Gu Y et al (2021) High pretreatment platelet-to-lymphocyte ratio is related to poor prognosis in the squamous cell carcinoma of the larynx and hypopharynx in male patients. Acta Otolaryngol 141(4):419–423
Park YM, Oh KH, Cho JG et al (2018) A prognostic scoring system using inflammatory response biomarkers in oral cavity squamous cell carcinoma patients who underwent surgery-based treatment. Acta Otolaryngol 138:422–427
Acharya S, Rai P, Hallikeri K, Anehosur V, Kale J (2017) Preoperative platelet lymphocyte ratio is superior to neutrophil lymphocyte ratio to be used as predictive marker for lymph node metastasis in oral squamous cell carcinoma. J Investig Clin Dent 8(3):e12219
Templeton AJ, McNamara MG, Šeruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106(6):124
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sharma, R., Kalsotra, G., Mahajan, D. et al. Prognostic Significance of Pre-Treatment Neutrophil–Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Head and Neck Malignancies. Indian J Otolaryngol Head Neck Surg 76, 567–574 (2024). https://doi.org/10.1007/s12070-023-04213-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-023-04213-2